PTGX — Biotech stock rising with exciting drug tests ahead; watch for chances to buy on small dips. | APLD — Tech infrastructure firm pushing AI and crypto data centers; hold and wait for a better price to buy. | NAMS — Healthcare company with promising drug trials and price gains; consider buying near support prices.
Healthcare
What it does
Protagonist makes special peptide medicines to treat blood and inflammation diseases. The stock recently climbed about 37% over the past year, nearing its all-time high around $67.
Why it matters today
This stock is popular because of its new medicines that could help many people, but prices can jump up and down a lot.
Price
$67.04
Action
BUY
Stop Loss
ProProfit Target
ProRisk/Reward Ratio: 1:2.0
🧭What to Do: Watch for small price dips to buy between $60 and $65 before key drug test news.
Why this matters to you
Uptrend
Risk level: Medium•Confidence:Pro
Technology
What it does
Applied Digital builds and runs big data centers for AI, crypto mining, and fast computing. The stock is near a year-high around $28.
Why it matters today
The company is growing but still losing money, so its stock price might go up and down.
Price
$28.07
Action
BUY
Stop Loss
ProProfit Target
ProRisk/Reward Ratio: 1:2.0
🧭What to Do: Hold for now; consider buying only if the price dips between $20 and $23.
Why this matters to you
Sideways to cautious uptrend
Risk level: Medium•Confidence:Pro
Healthcare
What it does
NewAmsterdam develops new medicines targeting metabolic and heart diseases. The stock price has gone up over 45% this year.
Why it matters today
The company's future depends a lot on how its new medicines perform in tests.
Price
$30.67
Action
BUY
Stop Loss
ProProfit Target
ProRisk/Reward Ratio: 1:2.0
🧭What to Do: Consider buying between $27 and $29 to lower risk while aiming for gains from new trial data.
Why this matters to you
Uptrend with possible short-term ups and downs
Risk level: Medium•Confidence:Pro